Ghrelin for Cachexia in Heart and Lung Disease: GH Release + Appetite + Cardiac Protection
Ghrelin's triple mechanism — GH release, appetite stimulation, and direct cardiac/pulmonary protection — makes it uniquely suited for treating cachexia (muscle wasting) in heart failure and chronic lung disease.
Quick Facts
What This Study Found
Ghrelin addresses cardiopulmonary cachexia through triple mechanism: GH-mediated anabolism, appetite stimulation to reverse wasting, and direct cardiac/pulmonary tissue protection — the most comprehensive single-agent approach to this devastating complication.
Key Numbers
How They Did This
review study on ghrp, cardiovascular.
Why This Research Matters
Relevant for ghrp, cardiovascular, muscle-recovery.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Ghrelin addresses cardiopulmonary cachexia through triple mechanism: GH-mediated anabolism, appetite stimulation to reverse wasting, and direct cardia
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2006.
- Original Title:
- Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.
- Published In:
- Internal medicine (Tokyo, Japan), 45(3), 127-34 (2006)
- Authors:
- Nagaya, Noritoshi(3), Kojima, Masakazu, Kangawa, Kenji(10)
- Database ID:
- RPEP-01169
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Ghrelin for Cachexia in Heart and Lung Disease: GH Release + Appetite + Cardiac Protection
What was found?
Ghrelin's triple mechanism — GH release, appetite stimulation, and direct cardiac/pulmonary protection — makes it uniquely suited for treating cachexia (muscle wasting) in heart failure and chronic lung disease.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01169APA
Nagaya, Noritoshi; Kojima, Masakazu; Kangawa, Kenji. (2006). Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.. Internal medicine (Tokyo, Japan), 45(3), 127-34.
MLA
Nagaya, Noritoshi, et al. "Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia.." Internal medicine (Tokyo, 2006.
RethinkPeptides
RethinkPeptides Research Database. "Ghrelin, a novel growth hormone-releasing peptide, in the tr..." RPEP-01169. Retrieved from https://rethinkpeptides.com/research/nagaya-2006-ghrelin-a-novel-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.